Oracle Investment Management’s Pfizer PFE Stock Holding History

Oracle Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-475,000	Closed	-$24.6M	–	37
2021 Q4	$28M	Buy	+475,000	New	+$23.5M	3.99%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oracle Investment Management's PFE Position: Q1 2022 in Review

Oracle Investment Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 475,000 shares — an estimated $24.6M sold.

Oracle Investment Management first reported a position in PFE in Q4 2021 and held it in 1 quarter. The position peaked at $28M in Q4 2021. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Oracle Investment Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
Oracle Investment Management sold 475,000 Pfizer shares in Q1 2022, an estimated $24.6M.
Oracle Investment Management first reported a position in Pfizer in Q4 2021 and held it in 1 quarter.
Oracle Investment Management's Pfizer position peaked at $28M in Q4 2021.
3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Oracle Investment Management's 13F filing for Q1 2022, filed 16 May 2022.